Proactive Investors - Run By Investors For Investors

eSense-Lab reveals robust antioxidant activity for its medical cannabis terpenes

eSense recently signed a deal to develop a beer product line that is infused with terpenes.
a doctor prescribing medical cannabis
Terpenes are responsible for the aroma of cannabis

eSense-Lab Ltd (ASX:ESE) has achieved robust antioxidant activity for its medical cannabis terpene blends, manifested by a dose response of up to 5%.

Terpenes are organic compounds found in plants and are responsible for the aroma of cannabis.

eSense conducted tests for antioxidant activity across its medical cannabis terpene blends including Girl Scout Cookies, OG-Kush, Sour Diesel, Jack Herer, Daniel, Super Lemon Haze, Gorilla Glue, Chees and Granddaddy Purple.

A clear antioxidant activity could be seen for each one of the tested blends.

Girl Scout Cookies, OG-Kush, Sour Diesel, Jack Herer and Daniel presented the most potent antioxidant activity, while Super Lemon Haze, Gorilla Glue, Chees and Granddaddy Purple were slightly weaker but still significantly active.

Chees and Gorilla Glue were tested in alignment with similar competitor's formulations and were found to be significantly more potent in terms of antioxidant activity.

eSense to develop a terpene-infused line of beer

The company recently signed a memorandum of understanding with Netherlands-based alcoholic beverages manufacturer Progressive Brands BV to develop a beer product line that is infused with terpenes.

eSense estimates a terpene-infused product from Progressive Brands can reach the market within six months.

Progressive Brands has the ability to produce circa one million bottles of the new terpene infused product once it is developed and commercialised.

Once launched to consumers by Progressive Brands, eSense will receive royalties from the sales of the product.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full ESE profile View Profile

esense-Lab Ltd Timeline

Newswire
January 11 2018

Related Articles

1541530050_california.jpg
November 01 2018
The 35,000 sq ft automated facility is equipped with proprietary fertigation, operational and security systems
1541165310_canadian-flag-1.jpg
November 03 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
cannabis leaf and green tablets
October 30 2018
The company will now proceed with stage II of the human clinical trial.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use